Vyant Bio Ownership | Who Owns Vyant Bio?
Vyant Bio Ownership Summary
Vyant Bio is owned by 5.78% institutional investors, and 94.22% retail investors. NT Ext Equity Mkt Idx Fd - NL is the top mutual fund, with 0.07% of its assets in Vyant Bio shares.
VYNT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Vyant Bio | 5.78% | - | 94.22% |
Sector | Healthcare Stocks | 47.25% | 8.01% | 44.75% |
Industry | Biotech Stocks | 45.35% | 7.81% | 46.83% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
NT Ext Equity Mkt Idx Fd - NL | 4.63K | 0.07% | - |
Northern Trust Extended Eq Market Idx | 4.11K | 0.07% | - |
NT Ext Equity Mkt Idx Fd - L | 4.11K | 0.07% | - |
NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 3.92K | 0.06% | 160.00 |
SSgA U.S. Extended Market Index Class I | 1.72K | 0.03% | - |
SSgA U.S. Total Market Index Strategy | 541.00 | 0.01% | -1.00 |
BlackRock Extended Mkt Composite | 224.00 | 0.00% | - |
NT US Market Cap Idx Fd - L | 13.00 | 0.00% | - |
Northern Trust Wilshire 5000 | 13.00 | 0.00% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 18, 2022 | Harris Geoffrey E. | - | Sell | $888.44 |
Nov 18, 2022 | Harris Geoffrey E. | - | Sell | $132.67 |
Nov 23, 2021 | LaFrence Andrew D.C. | Chief Financial Officer | Buy | $10.00K |
Dec 06, 2021 | Boehm Marcus | - | Buy | $8.45K |
Nov 24, 2021 | ROBERTS JOHN A | Chief Executive Officer | Buy | $10.10K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2023 Q1 | - | - |
2022 Q4 | - | 2 |
2022 Q3 | - | - |
2022 Q2 | - | - |
2022 Q1 | - | - |
VYNT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools